Indices

Indxx Global Generics & New Pharma Index

The Indxx Global Generics & New Pharma Index provides exposure to the 40 largest companies involved in manufacturing Generics, SuperGenerics, Biobetters and Biosimilars, and providing API manufacturing, CMO and CRO services to the pharmaceutical industry. The index has been backtested to March 18, 2005 and has a live calculation date of November 13, 2015.

IGNRXP
2022-07-06 00:00:00-3510.3039715207000
TR PR
Powered By

Back-tested performance is hypothetical and has certain inherent limitations. Back-tested performance differs from live performance and is included for informational purposes only.

Index Characteristics

Base Date 03/18/2005
No. of Constituents 23
Dividend Yield
*
0.15%
52 Week High/Low
**
4811/3236
* Trailing 12 months data for current year portfolio
** Trailing 12 months

Top 5 Index Constituents

Company Name Weight(%)
Samsung Biolog Ord 8.10%
Iqvia Holdings Ord 7.48%
Lonza Group Ord 7.32%
Celltrion Ord 6.98%
Icon Ord 6.22%

Index Risk & Return Statistics

Statistic QTD YTD 1 Year 3 Year Since Base Date
Beta
1
NA NA2 NA NA NA
Correlation
1
NA NA NA NA NA
Returns
2
2.18% -22.56% -21.32% 7.11% 7.53%
Standard Deviation 4.49% 21.15% 17.18% 17.72% 14.81%
1W.R.T.: Indxx 500 Index PR
2As of last trading day.
Fact Sheet is not available